Intensive and Critical Care Nursing
Volume 24, Issue 5 , Pages 269-285 , October 2008

Intermittent versus Continuous Renal Replacement Therapy: A matter of controversy

  • Hugh T. Davies

      Affiliations

    • Intensive Care Unit, Royal Perth Hospital, Western Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 8 9224 8020.
    • ,
  • Gavin D. Leslie

      Affiliations

    • Critical Care Nursing, Royal Perth Hospital and Curtin University of Technology, Western Australia

,Accepted 17 February 2008.

References 

  1. Abdeen O, Mehta RL. Dialysis modalities in the intensive care unit. Critical Care Clinics. 2002;18:223–247
  2. Abuclo J, Shemin D, Chazan J. Acute symptoms produced by haemodialysis: a review of their causes and associations. Seminars in Dialysis. 1993;6:59–69
  3. Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. American Journal of Kidney Diseases. 2004;44(6):1000–1007
  4. Baldwin I, Naka T, Koch B, Fealy N, Bellomo R. A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid–base balance. Intensive Care Medicine. 2007;33:830–835
  5. Bell M, Granath F, Schon S, Ekbom A, Claes-Roland M. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Medicine. 2007;33:773–780
  6. Bellomo R, Cole L, Reeves JH, Silvester W. Renal replacement therapy in the ICU: the Australian experience. American Journal of Kidney Diseases. 1997;30(Suppl. 4):S80–S83
  7. Bellomo R, Farmer M, Wright C, Parkin G, Boyce N. Treatment of sepsis-associated severe acute renal failure with continuous hemodiafiltration: clinical experience and comparison with conventional dialysis. Blood Purification. 1995;13:246–254
  8. Bellomo R, Mansfield D, Rumble S, Shapiro J, Parkin G, Boyce N. Acute renal failure in critical illness: Conventional dialysis versus acute continuous hemodiafiltration. American Society of Artificial Internal Organs Journal. 1992;38:M654–M657
  9. Bellomo R, Ronco C. Renal replacement therapy in the intensive care unit. Critical Care and Resuscitation. 1999;1:13–22
  10. Bellomo R, Ronco C. Continuous haemofiltration in the intensive care unit. Critical Care. 2000;4(6):339–345
  11. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Critical Care Medicine. 1993;21(4):522–526
  12. Berbece AN, Richardson RMA. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation and solute removal. Kidney International. 2006;70(5):963–968
  13. Conger JD. Does hemodialysis delay recovery from acute renal failure?. Seminars in Dialysis. 1990;3(3):146–148
  14. Coraim FI, Wolner E. Continuous hemofiltration for the failing heart. New Horizons. 1995;3(4):725–731
  15. Dahaba AA, Elawady GA, Rehak PH, List WF. Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients. Anaesthesia and Intensive Care. 2002;30(3):269–274
  16. Davenport A, Will EJ, Davison AM. Continuous vs. intermittent forms of haemofiltration and/or diaysis in the management of acute renal failure in patients with defective cerebral autoregulation at risk of cerebral oedema. Contributions to Nephrology. 1991;93:225–233
  17. de Vriese AS, Colardyn FA, Philippe JJ, Vanholder R, de Sutter JH, Lameire N. Cytokine removal during continuous hemofiltration in septic patients. Journal of the American Society of Nephology. 1999;10:846–853
  18. Dhondt A, van Holder R, van Biesen W, Lameire N. The removal of uremic toxins. Kidney International. 2000;58(Suppl. 76):S47–S59
  19. Dirkes SM, Hodge K. Continuous renal replacement therapy in the adult intensive care unit: history and current trends. Critical Care Nurse. 2007;27(2):61–80
  20. Foot CL, Fraser JF. So you need to start renal replacement therapy on your ICU patient?. Current Anaesthesia & Critical Care. 2005;16:321–329
  21. Gastaldello K, Melot C, Kahn R-J, Vanherweghem J-L, Vincent J-L, Tielemans C. Comparison of cellulose diacetate and poysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrology Dialysis Transplantation. 2000;15:224–230
  22. Gauthier PM, Szerlip HM. Metabolic acidosis in the intensive care unit. Critical Care Clinics. 2002;18:289–308
  23. Hakim RM. Hemodialysis membrane biocompatibility. Kidney International. 1993;44:484–494
  24. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. The New England Journal of Medicine. 1994;331(20):1338–1342
  25. Heering P, Grabensee B, Brause M. Cytokine removal in septic patients with continuous venovenous hemofiltration. Kidney & Blood Pressure Research. 2003;26:128–134
  26. Heering P, Morgera S, Schmitz FJ, Willers R, Schultheisis HP, Strauer BE, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Medicine. 1997;23:288–296
  27. Himmelfarb J. Continuous renal replacement therapy in the treatment of acute renal failure: critical assessment is required. Clinical Journal of the American Society of Nephrology. 2007;2:385–389
  28. Himmelfarb J, Rubin NT, Chandran P, Parker RA, Wingard RL, Hakim RM. A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. Journal of the American Society of Nephology. 1998;9:257–266
  29. Hoenich NA, Ronco C, Levin R. The importance of water quality and haemodialysis fluid composition. Blood Purification. 2006;24:11–18
  30. Hyman A, Mendelssohn DC. Current canadian approaches to dialysis for acute renal failure in the ICU. American Journal of Nephrology. 2002;22:29–34
  31. Jacka MJ, Ivancinova X, Gibbney N. Continuous renal replacement therapy improves renal recovery from acute renal failure. Canadian Journal of Anesthesia. 2005;52(3):327–332
  32. Jonee CH. Continuous renal replacement therapy in acute renal failure: membranes for CRRT. Artificial Organs. 1998;22(1):2–7
  33. Jorres A, Gahl GM, Dobis C, Polenakovic MH, Cakalaroski K, Rutkowski B, et al. Haemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: a prospective randomised multicentre trial. The Lancet. 1999;354:1337–1341
  34. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N, et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Medicine. 2002;28:29–37
  35. Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: A randomised controlled study. American Journal of Kidney Diseases. 2004;43(2):342–349
  36. Klenzak J, Himmelfarb J. Sepsis and the kidney. Critical Care Clinics. 2005;21:211–222
  37. Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Beraud JJ. Continuous veno-venous hemofiltration improves hemodynamics in septic shock without modifying TNF and IL6 plasma concentrations. Journal of Nephrology. 2002;15(2):150–157
  38. Kramer P, Kaufhold G, Grone HJ, Rieger J, Matthaei D, Stokke T, et al. Management of anuric intensive-care patients with arterio-venous haemofiltration. The International Journal of Artificial Organs. 1980;3:225–230
  39. Kumar VA, Craig M, Depner TA, Yeun JY. Extended daily dialysis: a new approach to renal replacement for acute renal failure in the intensive care unit. American Journal of Kidney Diseases. 2000;36(2):294–300
  40. Kumar VA, Yeun JY, Depner TA, Don BR. Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. The International Journal of Artificial Organs. 2004;27(5):371–379
  41. Lameire N, van Biesen W, van Holder R, Colardyn FA. The place of intermittent hemodialysis in the treatment of acute renal failure in the ICU patient. Kidney International. 1998;53(Suppl. 66):S110–S119
  42. Leunissen KML, van Hooff JP. Acetate or bicarbonate for haemodialysis?. Nephrology Dialysis Transplantation. 1988;3:1–7
  43. Leverve X, Barnoud D. Stress metabolism and nutritional support in acute renal failure. Kidney International. 1998;53(Suppl. 66):S62–S66
  44. Liano F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. Madrid acute renal failure study group. Kidney International. 1998;53(Suppl. 66):S16–S24
  45. Manns B, Doig CJ, Lee H, Dean S, Tonelli M, Johnson D, et al. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Critical Care Medicine. 2003;31(2):449–455
  46. Manns M, Sigler MH, Teehan BP. Intradialytic renal haemodynamics—potential consequences for the management of the patient with acute renal failure. Nephrology Dialysis Transplantation. 1997;12:870–873
  47. Marshall MR, Golper T, Shaver MJ, Chatoth DK. Hybrid renal replacement modalities for the critically ill. Contributions to Nephrology. 2001;132:252–257
  48. Marshall MR, Ma T, Galler D, Patrick A, Rankin N, Williams AB. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrology Dialysis Transplantation. 2004;19:877–884
  49. Martin PY, Chevrolet JC, Suter P, Favre H. Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. American Journal of Kidney Diseases. 1994;24:806–812
  50. Mc Donald BR, Mehta RL. Decreased mortality in patients with acute renal failure undergoing continuous arteriovenous hemodialysis. Contributions to Nephrology. 1991;93:51–56
  51. Mehta RL, Letteri JM. Current status of renal replacement therapy for acute renal failure. American Journal of Nephrology. 1999;19(3):377–382
  52. Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MTA, Farkas A, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney International. 2001;60:1154–1163
  53. Misset B, Timsit J-F, Chevret S, Renaud B, Tamion F, Carlet J. A randomized cross-over comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure. Intensive Care Medicine. 1996;22:742–746
  54. NHMRC (2005). National Health and Medical Research Council (NHMRC) additional levels of evidence and grades for recommendations for developers of guidelines: Pilot program 2005–2007. Canberra: Commonwealth of Australia.
  55. O’Reilly P, Tolwani AJ. Renal replacement therapy III: IHD, CRRT, SLED. Critical Care Clinics. 2005;21:367–378
  56. Overberger P, Pesacreta M, Palevsky PM. Management of renal replacement therapy in acute kidney injury: a survey of practitioner prescribing practices. Clinical Journal of the American Society of Nephrology. 2007;2:623–630
  57. Paganini EP, Tapolyai M, Goormastic M, Halstenberg W, Kozlowski L, Leblanc M, et al. Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. American Journal of Kidney Diseases. 1996;28(5 Suppl. (3)):S81–S89
  58. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney International. 1999;55:1991–1997
  59. Ponikvar JB, Rus RR, Kenda RB, Bren AF, Ponikvar R. Low-flux versus high-flux synthetic dialysis membrane in acute renal failure: prospective randomized study. Artificial Organs. 2001;25(12):946–950
  60. Ricci Z, Ronco C, D’amico G, Felice RD, Rossi S, Bolgan I, et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrology Dialysis and Transplantation. 2006;21:690–696
  61. Ronco C, Bellomo R, Homel P, Brendolan A, Maurizio D, Piccinni P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. The Lancet. 2000;356:26–30
  62. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. The New England Journal of Medicine. 2002;346(5):305–310
  63. Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. The Lancet. 1994;344:570–572
  64. Schortgen F, Soubrier N, Delclaux C, Thuong M, Girou E, Brun-Buisson C, et al. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients. American Journal of Respiratory and Critical Care Medicine. 2000;162:197–202
  65. Silvester W. Outcome studies of continuous renal replacement therapy in the intensive care unit. Kidney International. 1998;53(Suppl. 66):S138–S141
  66. Silvester W, Bellomo R, Cole L. Epidemiology, management and outcome of severe acute renal failure of critical illness in Australia. Critical Care Medicine. 2001;29:1910–1915
  67. Stefan J, Eckardt K-U. Renal replacement therapy in the treatment of acute renal failure: intermittent and continuous. Seminars in Dialysis. 2006;19(6):455–464
  68. Subramanian S, Venkataraman R, Kellum JA. Influence of dialysis membranes on outcomes in acute renal failure: a meta-analysis. Kidney International. 2002;62(5):1819–1823
  69. Swartz RD, Messana JM, Orzol S, Port FK. Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. American Journal of Kidney Diseases. 1999;34(3):424–432
  70. Thomas MC, Harris DCH. Problems and advantages of continuous renal replacement therapy. Nephrology. 2002;7(3):110–114
  71. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. American Journal of Kidney Diseases. 2002;40(5):875–885
  72. Uchino S, Bellomo R, Ronco C. Intermittent versus continuous renal replacement therapy in the ICU: impact on electrolyte and acid–base balance. Intensive Care Medicine. 2001;27:1037–1043
  73. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous is not continuous: the incidence and impact of circuit down-time on ureamic control during continuous veno-venous haemofiltration. Intensive Care Medicine. 2003;29:575–578
  74. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous venovenous hemofiltration without anticoagulation. American Society of Artificial Internal Organs Journal. 2004;50:76–80
  75. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Acute renal failure in critically ill patients. A multinational, multicenter study. Journal of the American Medical Association. 2005;294(7):813–818
  76. Uehlinger DE, Jakob SM, Ferrari P, Eichelberger M, Huynh-Do U, Marti H-P, et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrology Dialysis Transplantation. 2005;20:1630–1637
  77. van Biesen W, Vanholder R, Lameire N. Dialysis strategies in critically ill acute renal failure patients. Current Opinion in Critical Care. 2003;9:491–495
  78. van Bommel EFH. Are continuous therapies superior to intermittent haemodialysis for acute renal failure on the intensive care unit?. Nephrology Dialysis Transplantation. 1995;10:311–314
  79. van Bommel EFH, Bouvy ND, So KL, Zietse R, Vincent HH, Bruining HA, et al. Acute dialytic support for the critically ill: intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. American Journal of Nephrology. 1995;15:192–200
  80. van Bommel EFH, Ponssen HH. Intermittent versus continuous treatment for acute renal failure: where do we stand?. American Journal of Kidney Diseases. 1997;30(5 Suppl. 4):S72–S79
  81. van de Wetering J, Westendrop RGJ, van der Hoeven JG, Stolk B, Feuth JDM, Chang PC. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient haemorrhage. Journal of the American Society of Nephology. 1996;7(1):145–150
  82. Venkataraman R, Subramanian S, Kellum JA. Clinical review: extracorporeal blood purification in severe sepsis. Critical Care. 2003;7:139–145
  83. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, et al. Continous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. The Lancet. 2006;368:379–385
  84. Waldrop J, Ciraulo DL, Milner TP, Gregori D, Kendrick AS, Richart CM, et al. A comparison of continuous renal replacement therapy to intermittent dialysis in the management of renal insufficiency in the acutely ill surgical patient. The American Surgeon. 2005;71(1):36–39
  85. Ward DM, Mehta RL. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney International. 1993;43(Suppl. 41):S237–S244
  86. Wright SE, Bodenham A, Short AIK, Turney JH. The provision and practice of renal replacement therapy on adult intensive care units in the United Kingdom. Anaesthesia. 2003;58:1063–1069

PII: S0964-3397(08)00010-4

doi: 10.1016/j.iccn.2008.02.001

Intensive and Critical Care Nursing
Volume 24, Issue 5 , Pages 269-285 , October 2008

Article Tools

* Image Usage & Resolution